Published December 10, 2015 | Version v1
Journal article

cAMP effects in neuroendocrine tumors: The role of Epac and PKA in cell proliferation and adhesion

  • 1. Laboratory of Cellular and Molecular Endocrinology, IRCCS Clinical and Research Institute Humanitas, Rozzano (Italy)
  • 2. Fondazione IRCCS Ospedale Maggiore Policlinico, Endocrinology and Diabetology Unit, Department of Clinical Sciences and Community Health, University of Milan (Italy)
  • 3. Pancreas Surgery Unit, IRCCS Humanitas Clinical Institute, Rozzano (Italy)
  • 4. Medical Oncology and Hematology Unit, Cancer Center, Humanitas Clinical and Research Center, Milan, Rozzano (Italy)
  • 5. Endocrinology Unit, Humanitas Research Hospital, Milan, Rozzano (Italy)
  • 6. Department of Biomedical Sciences, Humanitas University, Milan, Rozzano (Italy)

Description

cAMP effects have been initially attributed to protein kinase A (PKA) activation. Subsequently, two exchange proteins directly activated by cAMP (Epac1/2) have been identified as cAMP targets. Aim of this study was to investigate cAMP effects in pancreatic-NET (P-NET) and bronchial carcinoids and in corresponding cell lines (QGP-1 and H727) on cell proliferation and adhesion and to determine PKA and Epac role in mediating these effects. We found that cAMP increased cyclin D1 expression in P-NET and QGP-1 cells, whereas it had opposite effects on bronchial carcinoids and H727 cells and it promoted cell adhesion in QGP-1 and H727 cells. These effects are mimicked by Epac and PKA specific analogs, activating the small GTPase Rap1. In conclusion, we demonstrated that cAMP exerted divergent effects on proliferation and promoted cell adhesion of different neuroendocrine cell types, these effects being mediated by both Epac and PKA and involving the same effector GTPase Rap1. - Highlights: • cAMP increased and decreased cell proliferation in different neuroendocrine cells. • cAMP divergent effects on proliferation are mimicked by both Epac and PKA. • cAMP and its effectors promoted cell adhesion in neuroendocrine tumor cells. • Epac and PKA act through the activation of same effector, Ras-like GTP-ase Rap1.

Availability note (English)

Available from http://dx.doi.org/10.1016/j.yexcr.2015.11.011

Additional details

Identifiers

DOI
10.1016/j.yexcr.2015.11.011;
PII
S0014-4827(15)30156-7;

Publishing Information

Journal Title
Experimental Cell Research
Journal Volume
339
Journal Issue
2
Journal Page Range
p. 241-251
ISSN
0014-4827
CODEN
ECREAL

INIS

Country of Publication
United States
Country of Input or Organization
International Atomic Energy Agency (IAEA)
INIS RN
49097330
Subject category
S60: APPLIED LIFE SCIENCES;
Descriptors DEI
ADHESION; AMP; CELL PROLIFERATION; GTP-ASES; NEOPLASMS; PANCREAS; PHOSPHOTRANSFERASES; PROLIFERATION; TUMOR CELLS
Descriptors DEC
ACID ANHYDRASES; ANIMAL CELLS; BODY; DIGESTIVE SYSTEM; DISEASES; ENDOCRINE GLANDS; ENZYMES; GLANDS; HYDROLASES; NUCLEOTIDES; ORGANIC COMPOUNDS; ORGANS; PHOSPHORUS-GROUP TRANSFERASES; PROTEINS; TRANSFERASES

Optional Information

Copyright
Copyright (c) 2015 Elsevier Science B.V., Amsterdam, The Netherlands, All rights reserved.